Longeviti, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, announced its patent for its ClearFit Implant.
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Alex Gorsky Joins Neurotech’s Board as Lead Director
Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer